Limits and uncertainty all-around telehealth reimbursement have usually been an impediment to adoption. In the course of the COVID-19 unexpected emergency, that burden was eased relatively, but now the new usual is starting up to choose form. What obstacles nevertheless continue being to telehealth reimbursement, and how may possibly they be triumph over? To respond to that question, host Jonah Comstock and Health care Finance News Managing Editor Susan Morse welcome McKinsey & Organization companions Oleg Bestsennyy and Gunjan Khanna.
This episode is brought to you by BlueJeans.
Like what you hear? Subscribe to the podcast on Apple Podcasts, Spotify or Google Perform!
- COVID-19 reimbursement changes and which of them will stick all-around
- Adoption lessons discovered and how they’ll influence reimbursement coverage
- Holistic tele-care and care beyond the online video stop by
- Influence of new entrants and innovation on the house
- Is rate-for-provider reimbursement an innovation blocker?
- Reimbursement for various telehealth modalities
- Time to lead fairly than observe for private payers?
- The nevertheless-unresolved question of induced utilization
- The rise of value-based mostly care and hybrid care designs
- Telehealth reimbursement and health and fitness fairness
- How are clients feeling about telehealth now?
- Remaining ideas: the future of telehealth reimbursement
Far more about this episode:
Report exhibits ‘vast improvement’ in state telehealth reimbursement guidelines
COVID-19 may well permanently alter the telehealth landscape, from reimbursement to utilization
Telehealth reimbursement parity spurs insurance company problems of overutilization
CMS will reimburse for 11 new telehealth companies all through the community health and fitness unexpected emergency
Congressional motion is wanted for telehealth not to return to a rural gain, Seema Verma claims
Telehealth: A quarter-trillion-greenback article-COVID-19 actuality? (McKinsey)
COVID-19 Client Health care Insights: What 2021 may well hold (McKinsey)
How COVID-19 has modified the way US consumers consider about healthcare (McKinsey)